Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07876505

Healthy Adult Participants Trial Comparing Different Cenvacibart Presentations

Conditions: Healthy Volunteers

Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 80
Sponsor: Regeneron Pharmaceuticals

Summary

This trial is being done in non-obese healthy participants to compare two different forms of cenvacibart. The main goal of the trial is to learn about the trial medicine and how it is absorbed, modified, and removed from the body. The trial will look at: * What side effects cenvacibart might cause and how it feels after the dose * Levels of cenvacibart in the blood at different time points * Whether the body makes proteins called antibodies against cenvacibart (which could make the trial medicine less effective or could lead to side effects) * What happens when cenvacibart travels through the body

Eligibility Criteria

Key Inclusion Criteria: 1. Is judged by the investigator to be in good health based on medical history, physical examination, laboratory tests, vital sign measurements, and electrocardiogram (ECG)performed at screening and/or prior to randomization as described in the protocol 2. Is in good health based on laboratory safety testing obtained at the screening visit and/or prior to randomization 3. Has a body weight within 50.0 and 95.0 kg (inclusive) and body mass index (BMI) within the range ≥18.5-\ 24 hours) for any reason within 30 days of the screening visit Note: Other Protocol Defined Inclusion/ Exclusion Criteria Apply

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07876505). StuddyBuddy aggregates publicly available trial information.